Celcuity (CELC) traded up 0.84 % during a 24 hours period ending at 05:31 AM Central Europe on Wednesday 28th. One Celcuity stock can currently be bought for about USD 68.07 on popular exchanges. Current supply of Celcuity stocks is 49 mn. Celcuity has a current market capitalization of USD 3.3 bn and approximately USD 122.8 mn worth of Celcuity was traded on exchanges in the last 24 hours. Since last month end, Celcuity has traded -17.38 % down. Simple moving average of last 200 days is at USD 101.4. The highest price of past 52 weeks was recorded at USD 151.02 on 05/04/2026. 52 weeks low was at USD 53.54 on 10/16/2026.
Here is how related stocks have performed in the past 24 hours:
Veracyte (VCYT) traded up 0.56 % and now trades at USD 50.28. Current market capitalisation for Veracyte is USD 3.9 bn. Veracyte has a current price to earnings ratio of 34.2.
Itron (ITRI) traded up 0.09 % and now trades at USD 94.55. Current market capitalisation for Itron is USD 3.9 bn. Current price/earnings ratio for Itron is 14.57.
Legence (LGN) traded up 2.66 % and now trades at USD 38.06. Legence has a market capitalisation of USD 3.9 bn.
Bread (BFH) traded up 1.83 % and now trades at USD 102.61. Bread has a market capitalisation of USD 3.9 bn. Bread has a current price to earnings ratio of 7.81.
Liquidia (LQDA) traded flat 0 % and now trades at USD 45.44. Liquidia has a market capitalisation of USD 3.9 bn. Current price/earnings ratio for Liquidia is 28.45.
About Celcuity
Celcuity Inc. is a clinical-stage biotechnology company based in Minneapolis, United States. The company specializes in the development of targeted therapies for the treatment of multiple solid tumor indications. As a health care industry biotechnology company, Celcuity serves clients in the United States. The company’s website is www.celcuity.com , and it is listed on the Nasdaq stock exchange. The date of its Initial Public Offering (IPO) was September 20, 2017.